PerkinElmer Accuses Genomic Solutions of Entering Sham Deal to Obstruct Previous Agreement | GenomeWeb

NEW YORK, Feb 16 – In its lawsuit against Genomic Solutions, PerkinElmer has alleged that  Genomic Solutions entered a “sham” proposed merger transaction in order to prevent PerkinElmer from being able to execute its call rights to acquire all of Genomic Solutions shares, according to documents PerkinElmer filed in Delaware Chancery Court.

 “GSI and its directors repeatedly have sought to construct and implement a sham transaction for the purpose of frustrating plaintiff’s contract rights,” states a motion obtained by GenomeWeb.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.